Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Cao

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Medicine|September 28, 2023
Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary PreventionMatteo Nardin, Monica Verdoia, Davide Cao, et al.
JAMA Cardiology|February 9, 2018
Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysisMauro Chiarito, Davide Cao, Francesco Cannata, et al.
Journal of Cardiovascular Development and Disease|July 25, 2025
Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term ManagementSimone Nardin, Beatrice Ruffilli, Pietro Costantini, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 28, 2021
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trialsMauro Chiarito, Davide Cao, Johny Nicolas, et al.
The Journal of Invasive Cardiology|May 23, 2023
Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC TrialRafaela Andrade Penalva Freitas, Luis Fernando Tanajura, Roxana Mehran, et al.
Lancet (London, England)|May 11, 2020
Monotherapy with a P2Y<sub>12</sub> inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysisMauro Chiarito, Jorge Sanz-Sánchez, Francesco Cannata, et al.
Lancet (London, England)|November 18, 2021
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registryRoxana Mehran, Ruth Owen, Mauro Chiarito, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 30, 2021
Types of myocardial injury and mid-term outcomes in patients with COVID-19Annapoorna Kini, Davide Cao, Matteo Nardin, et al.
Journal of the American College of Cardiology|June 23, 2022
Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the WeekMario Gaudino, Antonino Di Franco, Lisa Q Rong, et al.
JACC. Cardiovascular Interventions|February 14, 2024
Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary InterventionManish Vinayak, Davide Cao, Richard Tanner, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Medicine|September 28, 2023
Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary PreventionMatteo Nardin, Monica Verdoia, Davide Cao, et al.
JAMA Cardiology|February 9, 2018
Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysisMauro Chiarito, Davide Cao, Francesco Cannata, et al.
Journal of Cardiovascular Development and Disease|July 25, 2025
Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term ManagementSimone Nardin, Beatrice Ruffilli, Pietro Costantini, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 28, 2021
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trialsMauro Chiarito, Davide Cao, Johny Nicolas, et al.
The Journal of Invasive Cardiology|May 23, 2023
Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC TrialRafaela Andrade Penalva Freitas, Luis Fernando Tanajura, Roxana Mehran, et al.
Lancet (London, England)|May 11, 2020
Monotherapy with a P2Y<sub>12</sub> inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysisMauro Chiarito, Jorge Sanz-Sánchez, Francesco Cannata, et al.
Lancet (London, England)|November 18, 2021
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registryRoxana Mehran, Ruth Owen, Mauro Chiarito, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 30, 2021
Types of myocardial injury and mid-term outcomes in patients with COVID-19Annapoorna Kini, Davide Cao, Matteo Nardin, et al.
Journal of the American College of Cardiology|June 23, 2022
Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the WeekMario Gaudino, Antonino Di Franco, Lisa Q Rong, et al.
JACC. Cardiovascular Interventions|February 14, 2024
Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary InterventionManish Vinayak, Davide Cao, Richard Tanner, et al.
Pageof 15